- $1.46bn
- $1.38bn
- $534.53m
Brief: Atricure Reports Preliminary Results For Fourth Quarter And Full Year 2021, Provides Financial Outlook For 2022
U.S. RESEARCH ROUNDUP-Asana, Entergy, Qualys
AtriCure Inc reports results for the quarter ended in September - Earnings Summary
Brief: AtriCure Reports Q3 2021 Financial Results
AtriCure Inc expected to post a loss of 33 cents a share - Earnings Preview
Btig Says Covid: 19 uncertainty looms despite vaccinations push
Most medical device cos likely to achieve Q3 results targets- JPM
U.S. RESEARCH ROUNDUP- Continental Resources, GoDaddy, Revolve Group
AtriCure Inc reports results for the quarter ended in June - Earnings Summary
Brief: AtriCure Reports Data From Amaze Clinical Trial Did Not Achieve Statistical Superiority
Brief: AtriCure Reports Q2 Adj. Loss Per Share Of $0.30
AtriCure Inc expected to post a loss of 33 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Bank of America, Comerica, Wells Fargo & Co
Delta variant concerns could threaten recovery for medical device cos- BTIG
U.S. RESEARCH ROUNDUP-Churchill Downs, Doordash, MercadoLibre,
Brief: Atricure’S Epi-Sense System Approved By FDA For Treatment Of Long-Standing Persistent Afib Patients
U.S. RESEARCH ROUNDUP-Acushnet Holdings, Ecolab, Raytheon Technologies
AtriCure Inc reports results for the quarter ended in March - Earnings Summary
Brief: Atricure Reports First Quarter 2021 Financial Results